ALLO-IPSC Trademark

Trademark Overview

On Saturday, November 2, 2019, a trademark application was filed for ALLO-IPSC with the United States Patent and Trademark Office. The USPTO has given the ALLO-IPSC trademark a serial number of 88677998. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2023. This trademark is owned by Allogene Therapeutics, Inc.. The ALLO-IPSC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
allo-ipsc

General Information

Serial Number88677998
Word MarkALLO-IPSC
Filing DateSaturday, November 2, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 4, 2022SOU EXTENSION 5 GRANTED
Wednesday, October 26, 2022SOU EXTENSION 5 FILED
Thursday, November 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 4 GRANTED
Monday, April 25, 2022SOU EXTENSION 4 FILED
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2021SOU EXTENSION 3 GRANTED
Wednesday, November 10, 2021SOU EXTENSION 3 FILED
Wednesday, November 10, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 2 GRANTED
Thursday, April 15, 2021SOU EXTENSION 2 FILED
Thursday, April 15, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 1 FILED
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 6, 2020ASSIGNED TO EXAMINER
Wednesday, November 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 6, 2019NEW APPLICATION ENTERED

Related Keywords

ipsc allo preparations pharmaceutical including therapy immunotherapy cell tumors namely treatment cancer